RCOphth welcomes EU Court of Justice Advocate General’s new opinion on the use of ‘off-label’ drug Avastin
The Royal College of Ophthalmologists (RCOphth) believes that ophthalmologists should have the discretion to prescribe Bevacizumab (Avastin) or alternatives such as Ranibizumab (Lucentis) or Aflibercept (Eylea), whichever is the most appropriate treatment of age related macular degeneration (AMD) for the patient, and provided the patient gives informed consent. The RCOphth has long petitioned a review
RCOphth Statement on Ethambutol Toxicity
NHS Improvement has highlighted two recent incidents of severe visual loss due to delayed diagnosis of optic neuropathy from ethambutol. In 2015, 5758 cases of tuberculosis were notified in England and ethambutol is frequently prescribed in its initial phase of treatment Although ethambutol optic neuropathy is rare, members are strongly reminded of the possibility of
Assessment of a novel pinhole supplementary implant for sulcus fixation in pseudophakic cadaver eyes – (Eye, Published online: 27 October 2017; | doi:10.1038/eye.2017.239)
Assessment of a novel pinhole supplementary implant for sulcus fixation in pseudophakic cadaver eyes Eye, Published online: 27 October 2017; doi:10.1038/eye.2017.239
The quantitative assessment of alterations in lens transparency after transconjunctival 27-gauge microincision vitrectomy surgery – (Eye, Published online: 27 October 2017; | doi:10.1038/eye.2017.234)
The quantitative assessment of alterations in lens transparency after transconjunctival 27-gauge microincision vitrectomy surgery Eye, Published online: 27 October 2017; doi:10.1038/eye.2017.234
The presentation, clinical features, complications, and treatment of congenital dacryocystocele – (Eye, Published online: 27 October 2017; | doi:10.1038/eye.2017.235)
The presentation, clinical features, complications, and treatment of congenital dacryocystocele Eye, Published online: 27 October 2017; doi:10.1038/eye.2017.235